Remo M 100mg/1000mg Tablet

Description

Remo M Tablet is a combination antidiabetic therapy containing:

• Remogliflozin Etabonate 100 mg – a SGLT2 inhibitor that increases urinary glucose excretion, lowering blood sugar levels.

• Metformin 1000 mg – a biguanide that reduces glucose production in the liver and improves insulin sensitivity.

This combination is designed for patients with type 2 diabetes mellitus who require better glycemic control than either medication alone. By targeting different pathways of blood sugar regulation, it provides enhanced glucose control, weight management, and cardiovascular benefits.

Uses of Remo M Tablet

• Management of type 2 diabetes mellitus

• Helps lower blood sugar by dual mechanisms (kidney and liver)

• Assists in weight management in overweight diabetic patients

• Can be used when monotherapy is insufficient

• Reduces risk of hyperglycemia-related complications

How to Use

• Take as prescribed by your doctor, usually once or twice daily.

• Swallow the tablet whole with water, preferably with meals to reduce stomach upset.

• Monitor blood sugar regularly while on therapy.

• Combine with a diabetic diet, exercise, and lifestyle modifications for optimal results.

Side Effects

Common:

• Gastrointestinal upset (nausea, diarrhea, abdominal discomfort)

• Increased urination

• Thirst or mild dehydration

Less common but serious:

• Lactic acidosis (rare, related to Metformin)

• Severe urinary tract infections

• Low blood pressure (hypotension)

• Ketoacidosis – seek immediate medical attention

Precautions & Warnings

• Prescription Required – use only under medical supervision.

• Inform your doctor about kidney, liver, or heart problems before starting therapy.

• Maintain adequate hydration to prevent dehydration.

• Not recommended during pregnancy or breastfeeding unless prescribed.

• Regular kidney function tests and blood sugar monitoring are advised.

• Report unexplained muscle pain, fatigue, or severe abdominal pain immediately.

Conclusion

Remo M 100mg/1000mg Tablet (Remogliflozin Etabonate 100 mg + Metformin 1000 mg) is an effective dual-action antidiabetic therapy. By combining SGLT2 inhibition and Metformin’s hepatic glucose control, it lowers blood sugar, aids in weight management, and improves overall glycemic control. Proper use under medical supervision, along with diet and lifestyle measures, provides significant benefits in managing type 2 diabetes and preventing long-term complications.